FeesSafety
Pluang+

West Red Lake Gold unveils integrated mine plan boosting production to 100,000 oz/year with $200M capex.

Company Fundamentals
09 Nov 2026, 14:30 WIB
TheNewswire
View Source
Bullish
West Red Lake Gold unveils integrated mine plan boosting production to 100,000 oz/year with $200M capex.

West Red Lake Gold released a Pre-Feasibility Study for its integrated Madsen Mine and Rowan Project in Ontario, aiming to increase gold production to over 100,000 ounces annually by 2029. The plan leverages existing Madsen mill infrastructure to process ore from both sites, extending mine life to 10 years and improving operational efficiency. With a $200 million capital expenditure, the company targets a combined average grade of around 6.8 to 7 grams per tonne and aims to reduce costs as production scales. Development at Rowan is set to begin in 2028, supporting the company's transition to a multi-asset producer in the Red Lake district.

West Red Lake Gold's integrated Madsen Mine and Rowan Project Pre-Feasibility Study is the subject here, with Pluang market context provided for Basic Materials-sector stocks. As of Nov 09, 2026 19:12 WIB, 70 of 83 priced US stocks in this sector rose while 7 fell. Notable movers include Hudbay Minerals Inc. (HBM) at USD 21.76 (+4.07%), James Hardie Industries plc. (JHX) at USD 28.98 (+4.06%), and Aya Gold & Silver Inc. (AYA) at USD 26.36 (+3.90%).

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
1 hour ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
2 hours ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
2 hours ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
2 hours ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App